EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association Between C‐Reactive Protein–Triglyceride Glucose Index and Adverse Cardiovascular Outcomes in Acute Coronary Syndrome Patients With Prior Coronary Artery Bypass Grafting

Xiaoteng Ma iD, Huijun Chu, Qiuxuan Li, Yuxiu Yang iD, Zhijian Wang iD

Mediators of Inflammation · 2026-01 · 2026 (1)

DOI: 10.1155/mi/7921309 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mediators of Inflammation, online erschienen am 08.06.2026. Verfasst von Xiaoteng Ma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China, ccmu.edu.cn. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, C-Reactive Protein, Coronary Artery Bypass, Blood Glucose. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Municipal Natural Science Foundation, Capital's Funds for Health Improvement and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with acute coronary syndrome (ACS) who have previously undergone coronary artery bypass grafting (CABG) represent a complex, high‐risk population characterized by a substantial burden of atherosclerosis and a marked propensity for recurrent ischemic events. The pathophysiological interplay between systemic inflammation and insulin resistance serves as a key mediator driving the progression of atherosclerosis and the destabilization of atherosclerotic plaques. However, the prognostic impact of their combined effect, quantified by a novel composite biomarker—the C‐reactive protein–triglyceride glucose index (CTI)—remains uncertain in this specific high‐risk population.

Methods

We enrolled 1195 ACS patients with prior CABG who underwent percutaneous coronary intervention (PCI). The CTI was calculated as 0.412 × ln (high‐sensitivity C‐reactive protein [mg/L]) + ln (fasting triglycerides [mg/dL] × fasting blood glucose [mg/dL]/2). Patients were divided into three groups based on their CTI tertiles. The primary endpoint was defined as the occurrence of major adverse cardiovascular and cerebrovascular events (MACCE), which encompassed all‐cause death, nonfatal stroke, nonfatal myocardial infarction (MI), and unplanned revascularization.

Results

Over a median follow‐up of 3 years, 366 patients experienced MACCE. The incidence of MACCE progressively increased across CTI tertiles (log‐rank p < 0.001). In the multivariable Cox proportional hazards model adjusted for the GRACE (Global Registry of Acute Coronary Events) risk score and a comprehensive panel of clinical, procedural, and laboratory confounders, the highest CTI tertile remained an independent predictor of MACCE (adjusted hazard ratio [HR]: 3.864, 95% confidence interval [CI]: 2.710–5.511, p < 0.001). When CTI was analyzed as a continuous variable, each unit increase was found to confer an 80.1% greater risk of MACCE (adjusted HR: 1.801, 95% CI: 1.556–2.085, p < 0.001). This association remained consistent across all predefined subgroups. Adding CTI tertiles to the baseline model—which encompassed the GRACE risk score and other confounders—yielded a modest but statistically significant improvement in predictive performance ( C ‐statistic increased from 0.605 to 0.655, p < 0.001; continuous net reclassification improvement [cNRI]: 0.740, p = 0.032; integrated discrimination improvement [IDI]: 0.145, p = 0.020).

Conclusions

The CTI—a composite biomarker that captures both systemic inflammation and insulin resistance—emerged as a significant and independent predictor of long‐term MACCE in ACS patients with prior CABG who underwent PCI. Its integration into risk stratification models may improve prognostic assessment and potentially facilitate more personalized and intensive secondary prevention strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Coronary SyndromeC-Reactive ProteinCoronary Artery BypassBlood GlucoseTriglyceridesHumansMaleFemaleAgedMiddle AgedPercutaneous Coronary InterventionBiomarkersRisk Factors

Stichwörter der Autor:innen

C-reactive protein–triglyceride glucose indexacute coronary syndromecoronary artery bypass graftingmajor adverse cardiovascular and cerebrovascular eventspercutaneous coronary intervention

Substanzen

C-Reactive ProteinBlood GlucoseTriglyceridesBiomarkers

Autor:innen und Institutionen

  • Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China, ccmu.edu.cn.
  • Department of Anesthesia, Beijing Anzhen Hospital, Capital Medical University, Beijing, China, ccmu.edu.cn.

ORCID-Profile: Xiaoteng Ma, Yuxiu Yang, Zhijian Wang

Förderung

  • National Natural Science Foundation of China
  • Beijing Municipal Natural Science Foundation
  • Capital's Funds for Health Improvement and Research
  • Beijing Hospitals Authority Incubating Program

Zitieren

APA

Ma, X., Chu, H., Li, Q., Yang, Y., & Wang, Z. (2026). Association Between C‐Reactive Protein–Triglyceride Glucose Index and Adverse Cardiovascular Outcomes in Acute Coronary Syndrome Patients With Prior Coronary Artery Bypass Grafting. Mediators of Inflammation, 2026(1). https://doi.org/10.1155/mi/7921309

Vancouver

Ma X, Chu H, Li Q, Yang Y, Wang Z. Association Between C‐Reactive Protein–Triglyceride Glucose Index and Adverse Cardiovascular Outcomes in Acute Coronary Syndrome Patients With Prior Coronary Artery Bypass Grafting. Mediators of Inflammation. 2026;2026(1). doi:10.1155/mi/7921309

BibTeX
@article{Ma2026,
  author = {Ma, Xiaoteng and Chu, Huijun and Li, Qiuxuan and Yang, Yuxiu and Wang, Zhijian},
  title = {Association Between C‐Reactive Protein–Triglyceride Glucose Index and Adverse Cardiovascular Outcomes in Acute Coronary Syndrome Patients With Prior Coronary Artery Bypass Grafting},
  journal = {Mediators of Inflammation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/mi/7921309}
}
Kostenlos starten →